Zanamivir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
  • Influenza prophylaxis in those 5 years of age or older.
    • Not proven effective for prophylaxis in nursing home residents.

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
  • Influenza prophylaxis in those 5 years of age or older.
    • Not proven effective for prophylaxis in nursing home residents.

NON-FDA APPROVED USES

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: December 6, 2017